About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > PROFIT & LOSS
Profit & Loss      
Medicamen Biotech Ltd.
BSE Code 531146
ISIN Demat INE646B01010
Book Value 197.62
NSE Code MEDICAMEQ
Dividend Yield % 0.36
Market Cap 3718.92
P/E 42.03
EPS 6.52
Face Value 10  
(Rs. in Millions)
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :          
Gross Sales1514.60  1723.90  1378.80  1154.50  1101.47  
     Sales1514.60  1723.90  1378.80  1154.50  1101.47  
     Job Work/ Contract Receipts          
     Processing Charges / Service Income          
     Revenue from property development          
     Other Operational Income0.00  0.00  0.00  0.00  0.00  
Less: Excise Duty          
Net Sales1514.60  1723.90  1378.80  1154.50  1101.47  
EXPENDITURE :          
Increase/Decrease in Stock-60.80  -133.20  -103.00  -33.40  10.41  
Raw Material Consumed700.90  852.80  629.60  468.50  464.39  
     Opening Raw Materials155.50  180.30  115.80  18.00  82.76  
     Purchases Raw Materials642.60  827.90  694.10  566.40  399.62  
     Closing Raw Materials97.20  155.50  180.30  115.80  17.99  
     Other Direct Purchases / Brought in cost          
     Other raw material cost0.00  0.00  0.00  0.00  0.00  
Power & Fuel Cost69.40  71.20  56.70  58.60  26.83  
     Electricity & Power69.40  71.20  56.70  58.60  26.83  
     Oil, Fuel & Natural gas0.00  0.00  0.00  0.00  0.00  
     Coals etc0.00  0.00  0.00  0.00  0.00  
     Other power & fuel0.00  0.00  0.00  0.00  0.00  
Employee Cost215.70  221.20  185.70  145.00  87.92  
     Salaries, Wages & Bonus203.10  205.40  170.50  116.40  69.75  
     Contributions to EPF & Pension Funds12.00  12.60  11.40  8.40  5.82  
     Workmen and Staff Welfare Expenses0.70  3.20  3.80  20.20  12.34  
     Other Employees Cost0.00  0.00  0.00  0.00  0.00  
Other Manufacturing Expenses292.50  293.20  271.10  181.20  264.80  
     Sub-contracted / Out sourced services          
     Processing Charges44.60  45.00  39.70  40.20  33.73  
     Repairs and Maintenance18.70  15.00  13.30  18.50  16.30  
     Packing Material Consumed187.50  194.20  188.40  88.40  193.97  
     Other Mfg Exp41.80  39.00  29.70  34.10  20.80  
General and Administration Expenses70.70  69.00  51.90  49.20  26.27  
     Rent , Rates & Taxes3.90  4.70  4.00  3.70  2.85  
     Insurance4.60  3.30  1.30  1.20  1.18  
     Printing and stationery5.20  18.20  7.50  4.70  3.44  
     Professional and legal fees19.10  15.30  8.30  19.80  7.82  
     Traveling and conveyance11.50  8.80  7.20  3.80  1.44  
     Other Administration37.80  27.50  30.70  19.80  10.98  
Selling and Distribution Expenses52.20  64.80  29.20  33.60  17.13  
     Handling and Clearing Charges0.00  0.00  0.00  0.00  0.00  
     Other Selling Expenses0.00  0.50  1.00  0.30  1.85  
Miscellaneous Expenses3.00  12.50  11.60  10.70  3.44  
     Bad debts /advances written off          
     Provision for doubtful debts          
     Losson disposal of fixed assets(net)    0.10  0.00  0.01  
     Losson foreign exchange fluctuations          
     Losson sale of non-trade current investments          
     Other Miscellaneous Expenses3.00  12.50  11.50  10.70  3.43  
Less: Expenses Capitalised          
Total Expenditure1343.60  1451.50  1132.70  913.50  901.18  
Operating Profit (Excl OI)171.00  272.40  246.20  241.00  200.28  
Other Income62.30  23.10  24.60  17.20  7.54  
     Interest Received5.00  7.10  7.20  1.40  1.53  
     Dividend Received          
     Profit on sale of Fixed Assets  0.00        
     Profits on sale of Investments      0.00  0.04  
     Provision Written Back          
     Foreign Exchange Gains7.10  13.70  14.80  14.50  4.71  
     Others50.30  2.20  2.70  1.30  1.26  
Operating Profit233.40  295.40  270.80  258.20  207.82  
Interest36.00  56.50  33.90  19.40  15.12  
     InterestonDebenture / Bonds          
     Interest on Term Loan          
     Intereston Fixed deposits          
     Bank Charges etc5.50  12.70  4.70  5.40  4.48  
     Other Interest30.50  43.80  29.20  14.00  10.64  
PBDT197.40  239.00  236.90  238.80  192.71  
Depreciation69.60  70.10  63.50  57.70  25.20  
Profit Before Taxation & Exceptional Items127.70  168.90  173.30  181.00  167.51  
Exceptional Income / Expenses          
Profit Before Tax127.70  168.90  173.30  181.00  167.51  
Provision for Tax33.30  35.90  23.30  32.00  42.65  
     Current Income Tax36.40  42.20  37.00  39.80  41.45  
     Deferred Tax-3.10  -6.30  -13.70  -7.80  1.19  
     Other taxes0.00  0.00  0.00  0.00  0.00  
Profit After Tax94.50  133.00  150.00  149.10  124.87  
Extra items0.00  0.00  0.00  0.00  0.00  
Minority Interest          
Share of Associate          
Other Consolidated Items          
Consolidated Net Profit94.50  133.00  150.00  149.10  124.87  
Adjustments to PAT          
Profit Balance B/F941.80  821.50  683.20  544.30  425.56  
Appropriations1036.30  954.40  833.20  693.40  550.43  
     General Reserves          
     Proposed Equity Dividend          
     Corporate dividend tax          
     Other Appropriation10.20  12.70  11.80  12.20  6.11  
Equity Dividend %10.00  10.00  10.00  10.00  10.00  
Earnings Per Share7.00  10.00  12.00  12.00  10.00  
Adjusted EPS7.00  10.00  12.00  12.00  10.00  
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.